A highly sensitive sandwich-variety of EIA was used to measure the content of IgE in 144 sera and 59 samples of the bronchoalveolar fluid (BAF) of patients with pulmonary tuberculosis. As compared to normal persons, the content of serum IgE in the patients was significantly increased; the content of IgE in tuberculosis patients appeared as high as that in patients suffering from atopic allergy (pollenosis, bronchial asthma). The highest content of IgE was detected in patients with disseminated pulmonary tuberculosis, in the active disease phase, including those with bacterial isolation. The content of IgE was much higher in a group of patients with delayed process involution and inadequate treatment results than in a group with beneficial treatment results. The findings of the clinicoimmunological analysis permit the high content of serum IgE to be estimated as an unfavourable prognostic sign. In the BAF of patients with pulmonary tuberculosis, IgE was discovered in 30% of cases. A good correlation was noted between the IgE content in the serum and the frequency of IgE demonstration in the BAF.

Download full-text PDF

Source

Publication Analysis

Top Keywords

content ige
16
patients pulmonary
12
pulmonary tuberculosis
12
content serum
12
ige
9
bronchoalveolar fluid
8
patients
8
baf patients
8
serum ige
8
content
7

Similar Publications

Theoretical and practical considerations for validating antigen-specific B cell ImmunoSpot assays.

J Immunol Methods

January 2025

Research & Development Department, Cellular Technology Limited, Shaker Heights, OH 44122, USA. Electronic address:

Owing to their ability to reliably detect even very rare antigen-specific B cells in cellular isolates such as peripheral blood mononuclear cells (PBMC), and doing so robustly in a high throughput-compatible manner, B cell ELISPOT/FluoroSpot (collectively "B cell ImmunoSpot") tests have become increasingly attractive for immune monitoring in regulated settings. Presently, there are no guidelines for the qualification and validation of B cell ImmunoSpot assay results. Here, we propose such guidelines, building on the experience acquired from T cell ImmunoSpot testing in an environment adhering to the requirements of regulatory bodies yet taking the unique features of B cell assays into account.

View Article and Find Full Text PDF

: The utilization of maternal health services at the primary healthcare level is still considered an effective approach despite the critical role in improving maternal health outcomes. The study aimed to assess the influence of sociodemographic characteristics and interpersonal support on the use of maternal health services in three regions of the Province of Jambi, Indonesia. : Using a mixed-methods sequential explanatory design, a quantitative survey of 432 women and qualitative focus group discussions with nine families were conducted.

View Article and Find Full Text PDF

Exposure to ambient particulate matter (PM) with an aerodynamic diameter of <10 μm (PM) is a well-established health hazard. There is increasing evidence that geogenic (Earth-derived) particles can induce adverse biological effects upon inhalation, though there is high variability in particle bioreactivity that is associated with particle source and physicochemical properties. In this study, we investigated physicochemical properties and biological reactivity of volcanic ash from the April 2021 eruption of La Soufrière volcano, St.

View Article and Find Full Text PDF

A Combined Extract from and Mitigates PM-Induced Respiratory Damage by NF-κB/TGF-β1 Pathway.

Antioxidants (Basel)

December 2024

Division of Applied Life Science (BK21), Institute of Agriculture and Life Science, Gyeongsang National University, Jinju 52828, Republic of Korea.

This research evaluated the protective role of a combined extract of and (DBZO) against respiratory dysfunction caused by particulate matter (PM) exposure in BALB/c mice. The bioactive compounds identified in the DBZO are catechin, astragalin, 6-gingerol, 8-gingerol, and 6-shogaol. DBZO ameliorated cell viability and reactive oxygen species (ROS) production in PM-stimulated A549 and RPMI 2650 cells.

View Article and Find Full Text PDF

Background: The treatment of refractory chronic rhinosinusitis with nasal polyps (CRSwNP) with omalizumab has been well studied based on clinical evaluation. Nevertheless, ideal quantitative or qualitative biomarkers for predicting a different response to biologics urgently need to be explored. We aim to identify potential biomarkers for predicting a good or poor response in patients with refractory CRSwNP.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!